Form D · Biotechnology
Quadric BioMed, LLC
Colorado Springs, CO · CIK 0001726091
Offering snapshot reported Apr 25, 2023 · SEC filing
- Reported sold
- $550K Offering amount: $750K
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $15K Reported outside-investor minimum
- First sale
- Jan 6, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 25, 2023 | Initial | $550,290 | No comparison | 13 | SEC filing |
| Dec 29, 2017 | Initial | $74,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04, 06b, 4a5
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-479878
Source: Form D, filed Apr 25, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Aaron Bass | Executive |
| Ric Denton | Director, Executive |
| James Grant | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1755 Telstar Drive, Suite 300
Colorado Springs, CO, 80920
Colorado Springs, CO, 80920